[Latest] Global Cloud Endpoint Protection Market Size/Share Worth USD 23.6 Billion by 2033 at a 22.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
02. Oktober 2024 02:30 ET
|
Custom Market Insights
Austin, TX, USA, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Cloud Endpoint Protection Market Size, Trends and Insights By Component...
Interpace Biosciences Announces Record Second Quarter 2023 Financial and Business Results
09. August 2023 12:30 ET
|
Interpace Biosciences, Inc.
●Q2 Revenue of $11.0 million; a 49% increase year-over-year; highest quarter in history ●Q2 Test volume up 15% year over year to record levels ●Q2 Reimbursement improvement up 34% year-over-year...
Interpace Biosciences Announces Update of Previously Announced CMS Billing Policy Impacting its Thyroid Tests
22. Februar 2022 09:00 ET
|
Interpace Biosciences, Inc.
PARSIPPANY, NJ, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (OTCQX: IDXG) (“Interpace” or the “Company”), a leader in enabling personalized medicine, announced today that the...
Interpace Biosciences Announces Improved Coverage for ThyGeNEXT® and ThyraMIR®
03. Mai 2021 08:00 ET
|
Interpace Biosciences, Inc.
Parsippany, NJ, May 03, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) announced today that eviCore Healthcare (“eviCore”), a wholly owned...
Interpace Biosciences Raises Full Year 2021 Revenue Guidance
19. April 2021 07:05 ET
|
Interpace Biosciences, Inc.
Parsippany, NJ, April 19, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced an update to its full year 2021 revenue guidance...
Interpace Biosciences to Host Third Quarter 2020 Financial Results Conference Call on Thursday, January 21, 2021
20. Januar 2021 15:38 ET
|
Interpace Biosciences, Inc.
PARSIPPANY, NJ, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (NASDAQ: IDXG) announced today that it will hold its third quarter 2020 financial results conference call and webcast...
Interpace Biosciences Receives Nasdaq Deficiency Notice Due to Delayed Filing of Form 10-Q; No Immediate Impact on Listing
20. August 2020 08:30 ET
|
Interpace Biosciences, Inc.
PARSIPPANY, NJ, Aug. 20, 2020 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (NASDAQ: IDXG) on August 18, 2020 received notice from the Listing Qualifications Staff...
Checkmate Capital Invests in Community Eco Power
18. September 2019 09:00 ET
|
Checkmate Capital
LOS ANGELES, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Checkmate Capital has completed an investment in Community Eco Power (CEP), a leader in the waste-to-energy industry headquartered in Asheville, North...
Q2Earth Signs Services Agreement in Connection with Acquisition of Two Waste-to-Energy Plants in New England
21. Mai 2019 08:30 ET
|
Q2Earth, Inc
Palm Beach, FL, May 21, 2019 (GLOBE NEWSWIRE) -- Q2Earth, Inc. (OTCQB: QPWR) (the “Company” or “Q2”) has signed a services agreement to oversee the operational, legal and financial closing of the...
Interpace Diagnostics Labs Receive College of American Pathology (CAP) Accreditation
25. April 2019 06:55 ET
|
Interpace Diagnostics Group, Inc.
Pennsylvania and Connecticut Labs Both Receive Accreditation PARSIPPANY, NJ, April 25, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that it has...